Cargando…

Tumor budding correlates with tumor invasiveness and predicts worse survival in pT1 non-muscle-invasive bladder cancer

Tumor budding is defined as a single cell or a cluster of up to 5 tumor cells at the invasion front. Due to the difficulty of identifying patients at high risk for pT1 non-muscle-invasive bladder cancer (NMIBC) and the difficulties in T1 substaging, tumor budding was evaluated as a potential alterna...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eckstein, Markus, Kimmel, Charlotte, Bruendl, Johannes, Weber, Florian, Denzinger, Stefan, Gierth, Michael, Burger, Maximilian, Hartmann, Arndt, Otto, Wolfgang, Breyer, Johannes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429693/ https://www.ncbi.nlm.nih.gov/pubmed/34504238 http://dx.doi.org/10.1038/s41598-021-97500-3

Ejemplares similares

Aquaporin 3 Expression Loss in Urothelial Carcinoma: Association with Tumor Invasion Depth, but not with Grading?
por: Breyer, Johannes, et al.
Publicado: (2017)

High Stroma T-Cell Infiltration is Associated with Better Survival in Stage pT1 Bladder Cancer
por: Hülsen, Sabine, et al.
Publicado: (2020)

Epidemiology and therapy of symptomatic lymphoceles after robot-assisted radical prostatectomy (RARP)
por: Goßler, Christopher, et al.
Publicado: (2021)

High Androgen Receptor mRNA Expression Is Independently Associated with Prolonged Cancer-Specific and Recurrence-Free Survival in Stage T1 Bladder Cancer
por: Sikic, Danijel, et al.
Publicado: (2017)

Increased Proliferation as Independent Predictor of Disease Recurrence in Initial Stage pTa Urothelial Bladder Cancer
por: Breyer, Johannes, et al.
Publicado: (2017)

mRNA-Expression of KRT5 and KRT20 Defines Distinct Prognostic Subgroups of Muscle-Invasive Urothelial Bladder Cancer Correlating with Histological Variants
por: Eckstein, Markus, et al.
Publicado: (2018)

CDKN2A as transcriptomic marker for muscle-invasive bladder cancer risk stratification and therapy decision-making
por: Worst, Thomas S., et al.
Publicado: (2018)

The Prognostic Value of FGFR3 Expression in Patients with T1 Non-Muscle Invasive Bladder Cancer
por: Sikic, Danijel, et al.
Publicado: (2021)

High Androgen Receptor mRNA Expression Is Associated with Improved Outcome in Patients with High-Risk Non-Muscle-Invasive Bladder Cancer
por: Sikic, Danijel, et al.
Publicado: (2021)

FOXM1 predicts disease progression in non-muscle invasive bladder cancer
por: Rinaldetti, Sebastien, et al.
Publicado: (2018)

Loss of aquaporin 3 protein expression constitutes an independent prognostic factor for progression-free survival: an immunohistochemical study on stage pT1 urothelial bladder cancer
por: Otto, Wolfgang, et al.
Publicado: (2012)

FOXM1 predicts overall and disease specific survival in muscle-invasive urothelial carcinoma and presents a differential expression between bladder cancer subtypes
por: Rinaldetti, Sebastien, et al.
Publicado: (2017)

FOXA1 Gene Expression for Defining Molecular Subtypes of Muscle-Invasive Bladder Cancer after Radical Cystectomy
por: Sikic, Danijel, et al.
Publicado: (2020)

Predictive value of molecular subtyping in NMIBC by RT-qPCR of ERBB2, ESR1, PGR and MKI67 from formalin fixed TUR biopsies
por: Breyer, Johannes, et al.
Publicado: (2017)

Improving outcome and prognosis prediction in non-muscle invasive bladder cancer using a gene expression score
por: Breyer, Johannes
Publicado: (2017)

Cytotoxic T-cell-related gene expression signature predicts improved survival in muscle-invasive urothelial bladder cancer patients after radical cystectomy and adjuvant chemotherapy
por: Eckstein, Markus, et al.
Publicado: (2020)

Tumor budding and fibrotic focus—proposed grading system for tumor budding in invasive carcinoma no special type of the breast
por: Hiratsuka, Miyuki, et al.
Publicado: (2022)

Immunotherapy in urothelial carcinoma: fade or future standard?
por: Breyer, Johannes, et al.
Publicado: (2016)

Prognostic significance of tumor budding and single cell invasion in gastric adenocarcinoma
por: Che, Keying, et al.
Publicado: (2017)

Vacuum-assisted closure therapy in ureteroileal anastomotic leakage after surgical therapy of bladder cancer
por: Denzinger, Stefan, et al.
Publicado: (2007)

DAPK1 loss triggers tumor invasion in colorectal tumor cells
por: Steinmann, Sara, et al.
Publicado: (2019)

Sporadic renal cell carcinoma in young and elderly patients: are there different clinicopathological features and disease specific survival rates?
por: Denzinger, Stefan, et al.
Publicado: (2007)

A Metachronous, Atypical, Multifocal Renal Oncocytoma with a Concomitant Renal Cell Carcinoma of the Contralateral Side and Bilateral Multifocal Oncocytomas: Two Case Reports and Review of Literature
por: Burger, Maximilian, et al.
Publicado: (2005)

Transcriptional upregulation of c-MET is associated with invasion and tumor budding in colorectal cancer
por: Bradley, Conor A., et al.
Publicado: (2016)

TP53 mutations in functional corticotroph tumors are linked to invasion and worse clinical outcome
por: Perez-Rivas, Luis Gustavo, et al.
Publicado: (2022)

Tumor heterogeneity in muscle-invasive bladder cancer
por: Kang, Ho Won, et al.
Publicado: (2020)

Depth of invasion, tumor budding, and worst pattern of invasion: Prognostic indicators in early-stage oral tongue cancer
por: Almangush, Alhadi, et al.
Publicado: (2014)

Joint Tumor Bud–MMP/TIMP Count at the Invasive Front Improves the Prognostic Evaluation of Invasive Breast Carcinoma
por: González, Luis O., et al.
Publicado: (2021)

A Retrospective Study of Association of Tumor Budding, Tumor Microenvironment, and Clinicopathological Characteristics of Invasive Breast Carcinoma
por: Singh, Tanwi, et al.
Publicado: (2022)

A multicenter round robin test of PD-L1 expression assessment in urothelial bladder cancer by immunohistochemistry and RT-qPCR with emphasis on prognosis prediction after radical cystectomy
por: Eckstein, Markus, et al.
Publicado: (2018)

Androgen Receptor mRNA Expression in Urothelial Carcinoma of the Bladder: A Retrospective Analysis of Two Independent Cohorts
por: Sikic, Danijel, et al.
Publicado: (2019)

Xpert bladder cancer monitor to predict the need for a second TURB (MoniTURB trial)
por: Breyer, Johannes, et al.
Publicado: (2023)

Prognostic Value of Molecular Breast Cancer Subtypes based on Her2, ESR1, PGR and Ki67 mRNA-Expression in Muscle Invasive Bladder Cancer
por: Kriegmair, M.C., et al.
Publicado: (2018)

Positive fibroblast growth factor receptor 3 immunoreactivity is associated with low-grade non-invasive urothelial bladder cancer
por: POYET, CÉDRIC, et al.
Publicado: (2015)

Tumor budding and tumor‐infiltrating lymphocytes can predict prognosis in pT1b esophageal squamous cell carcinoma
por: Li, Zhuo, et al.
Publicado: (2023)

New Histoprognostic Factors to Consider for the Staging of Colon Cancers: Tumor Deposits, Invasive Tumor Infiltration and High-Grade Budding
por: Riffet, Marc, et al.
Publicado: (2023)

Subtype specific expression and survival prediction of pivotal lncRNAs in muscle invasive bladder cancer
por: Rinaldetti, Sebastien, et al.
Publicado: (2020)

Predictive factors for residual tumor and tumor upstaging on relook transurethral resection of bladder tumor in non-muscle invasive bladder cancer
por: Gill, Tejpal S., et al.
Publicado: (2014)

Subclassification, survival prediction and drug target analyses of chemotherapy-naïve muscle-invasive bladder cancer with a molecular screening
por: Rinaldetti, Sebastien, et al.
Publicado: (2018)

DAPK loss in colon cancer tumor buds: implications for migration capacity of disseminating tumor cells
por: Ivanovska, Jelena, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_4ef09eu4u72d4jkat1vu85ugce